Clinical Trials in Illinois

Showing 5701-5720 of 14,943 trials

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

NCT03529942

This is an open-label study assessing the effect of the administration of a single intra-articular (IA) injection of FX006 32 mg on synovial volume in patients with osteoarthritis (OA) of the knee.

Osteoarthritis, Knee

Pacira Pharmaceuticals, Inc129 participantsStarted Apr 2018

El Cajon, California, United States • La Mesa, California, United States • Pomona, California, United States +7 more locations

TERMINATEDPhase 1125 miles

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

NCT04025216

Multi-center, open-label, first in human Phase 1 study of the safety, tolerability, feasibility, and preliminary efficacy of the administration of genetically modified autologous T cells (CART-TnMUC1 cells) engineered to express a chimeric antigen receptor (CAR) capable of recognizing the tumor antigen, TnMUC1 and activating the T cell (CART- TnMUC1 cells).

Non-Small Cell Lung CancerOvarian CancerFallopian Tube Cancer+3 more

Kite, A Gilead Company16 participantsStarted Oct 2019

Phoenix, Arizona, United States • Los Angeles, California, United States • Tampa, Florida, United States +7 more locations

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Find Trials by Condition in Illinois

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

Growth and Tolerance of a Partially Hydrolyzed Infant Formula

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

Tracking Renal Tumors After Cryoablation Evaluation

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt

EPI-743 for Mitochondrial Respiratory Chain Diseases

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip